1. Midha KK, McKay G. Bioequivalence; its history, practice, and future. AAPS J. 2009;11(4):664–70.
2. Bae JW, Jang CG, Lee SY. Methods for pharmacodynamic analysis and proposed protocols for bioequivalence study of acarbose. Yakhak Hoeji. 2007;51(6):440–6.
3. U.S. Department of Health and Human Services, Food and Drug Administration. Contains nonbinding recommendations: draft Guidance on Acarbose.
http://www.fda.gov/downloads/Drugs/Guidance
Compliance Regulatory Information/Guidances/UCMI170242.pdf
4. Koytchev R, Richter W, Erkent U, Kirkov V, Dimitrova V, Nern A, Kunter U. Influence of acarbose on blood glucose and breath hydrogen after carbohydrate load with sucrose or starch. Arzneimittelforschung. 2001;59(11):557–63.
5. Wang Z, Li L, Zheng F, Jia C, Ruan Y, Li H. Correlation between the amplitude of glucose excursion and the oxidative/antioxidative system in subjects with different types of glucose regulation. Biomed Environ Sci. 2011;24(1):68–73.